Market Closed -
Other stock markets
|
Pre-market 08:08:08 | |||
128.7 USD | -0.49% | 129 | +0.29% |
05-14 | US FDA declines to approve expanded use of Dynavax's hepatitis B vaccine | RE |
05-13 | Merck: phase 3 trial in melanoma halted | CF |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.02% | 326B | |
+31.17% | 588B | |
-3.42% | 364B | |
+4.27% | 285B | |
+14.98% | 239B | |
+9.97% | 210B | |
-7.65% | 200B | |
+8.12% | 167B | |
-1.42% | 161B | |
+1.27% | 124B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. Presents at ACC.23 Together With The 2023 World Congress of Cardiology, Mar-04-2023 through Mar-06-2023